GIMBHI’s daily mental health update — 1/29/26

🤝 Sword Health acquires Kaia Health for $285M to expand U.S. scale and enter Germany (Jessica Hagen, MobiHealthNews) — 01/28/26
TL;DR: Sword Health bought digital therapeutics firm Kaia Health in a $285M deal, replacing Kaia’s MSK product in the U.S. while leveraging Kaia’s reimbursed digital health presence in Germany, and strengthening Sword’s AI-enabled physical and mental health platform footprint globally.

🧪 Anti-inflammatory treatments show benefit for depression and anhedonia in patients with elevated inflammation (Kenneth J. Bender, Psychiatric Times) — 01/27/26
TL;DR: A meta-analysis of randomized trials found that anti-inflammatory treatments reduced depressive symptoms and anhedonia in patients with elevated CRP levels, suggesting an inflammatory subtype of depression that responds poorly to standard antidepressants but may benefit from targeted or lifestyle-based anti-inflammatory approaches.

🧠 Federal funding chaos rattles Nevada mental health providers (Grace Da Rocha, Las Vegas Sun) — 01/29/26
TL;DR: A brief but severe federal grant cancellation and reversal left Nevada mental health providers scrambling, exposing how fragile the state’s already strained mental health and substance abuse care system has become.